UPDATE: Catalyst Pharmaceutical (CPRX) Whipsawed
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Join SI Premium – FREE
(Updated - October 9, 2013 10:45 AM EDT)
Catalyst Pharmaceutical (Nasdaq: CPRX) stock experienced wild trading on Wednesday, plunging 20% before a halt. The stock later recovered losses. Traders were at a loss to explain the exact cause of the move, and it is being tied loosely to broader sector weakness, with shares of other pharma stocks also seeing weakness.
Catalyst Pharmaceutical (Nasdaq: CPRX) stock experienced wild trading on Wednesday, plunging 20% before a halt. The stock later recovered losses. Traders were at a loss to explain the exact cause of the move, and it is being tied loosely to broader sector weakness, with shares of other pharma stocks also seeing weakness.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Qualcomm plans new chip architecture for phones - Semafor
- Perfect Moment (PMNT) Halted, News Pending
- Sinda opens at $10.80, IPO priced at $12
Create E-mail Alert Related Categories
Insiders' Blog, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
